These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 14755063)

  • 1. Compounded versus proprietary sincalide for evaluation of gallbladder ejection fraction.
    Guarasci DT; Trinh LH; Baeumler GR; Bednarczyk EM
    Ann Pharmacother; 2004 Mar; 38(3):428-32. PubMed ID: 14755063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Normal Gallbladder Ejection Fraction Occurring Unexpectedly Obviates Need for Sincalide Stimulation.
    Hadi S; Tulchinsky M
    Clin Nucl Med; 2017 May; 42(5):394-396. PubMed ID: 28221193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis of BD relied in great measure on gallbladder ejection fraction (GBEF) after sincalide stimulation on hepatobiliary scintigraphy.
    Tulchinsky M
    J Pediatr Surg; 2009 Oct; 44(10):2059; author reply 2059-60. PubMed ID: 19853777
    [No Abstract]   [Full Text] [Related]  

  • 4. Sincalide-stimulated cholescintigraphy: a multicenter investigation to determine optimal infusion methodology and gallbladder ejection fraction normal values.
    Ziessman HA; Tulchinsky M; Lavely WC; Gaughan JP; Allen TW; Maru A; Parkman HP; Maurer AH
    J Nucl Med; 2010 Feb; 51(2):277-81. PubMed ID: 20080900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of gallbladder function obtained with regular CCK-8 and pharmacy-compounded CCK-8.
    Krishnamurthy S; Cerulli-Switzer J; Chapman N; Krishnamurthy GT
    J Nucl Med; 2003 Apr; 44(4):499-504. PubMed ID: 12679391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gallbladder ejection fraction: correlation of scintigraphic and ultrasonographic techniques.
    Siegel A; Kuhn JC; Crow H; Holtzman S
    Clin Nucl Med; 2000 Jan; 25(1):1-6. PubMed ID: 10634521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What value is normal for gallbladder ejection fraction, and how is it established?
    Krishnamurthy GT; Krishnamurthy S
    Radiology; 2003 Feb; 226(2):593-4; author reply 594-5. PubMed ID: 12563160
    [No Abstract]   [Full Text] [Related]  

  • 8. Should the presence of other diseases exclude subjects as controls in studies of gallbladder response to cholecystokinin octapeptide (sincalide)? Scintigraphic results in patients with malignancies but no known gallbladder disease.
    Jacobson AF; Teefey SA
    Nucl Med Commun; 1996 Jun; 17(6):514-9. PubMed ID: 8822750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional hepatobiliary disease: chronic acalculous gallbladder and chronic acalculous biliary disease.
    Ziessman HA
    Semin Nucl Med; 2006 Apr; 36(2):119-32. PubMed ID: 16517234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can sincalide cholescintigraphy fulfil the role of a gall-bladder stress test for patients with gall-bladder stones?
    Gani JS
    Aust N Z J Surg; 1998 Jul; 68(7):514-9. PubMed ID: 9669367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimation of gallbladder ejection fraction utilizing cholecystokinin-stimulated magnetic resonance cholangiography and comparison with hepatobiliary scintigraphy.
    Vyas PK; Vesy TL; Konez O; Ciavellara DP; Hua K; Gaisie G
    J Magn Reson Imaging; 2002 Jan; 15(1):75-81. PubMed ID: 11793460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Normal gallbladder ejection fraction after morphine augmentation.
    Achong DM; Oates E
    Clin Nucl Med; 1999 Nov; 24(11):837-41. PubMed ID: 10551461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of cholecystokinin-stimulated cholescintigraphy in the diagnosis and treatment of acalculous gallbladder disease.
    Mishkind MT; Pruitt RF; Bambini DA; Hakenewerth AM; Thomason MH; Zuger JH; Novick T
    Am Surg; 1997 Sep; 63(9):769-74. PubMed ID: 9290518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Normal values for sincalide cholescintigraphy: comparison of two methods.
    Ziessman HA; Muenz LR; Agarwal AK; ZaZa AA
    Radiology; 2001 Nov; 221(2):404-10. PubMed ID: 11687683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sincalide: A Review of Clinical Utility, Proper Infusion Methodology, and Alternative Cholecystogogues.
    Ziessman HA
    J Nucl Med Technol; 2019 Sep; 47(3):210-212. PubMed ID: 31019045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of hepatobiliary scintigraphy in patients with acalculous biliary colic.
    Halverson JD; Garner BA; Siegel BA; Alexander R; Edmundowicz SA; Campbell W; Miller JE
    Arch Intern Med; 1992 Jun; 152(6):1305-7. PubMed ID: 1599361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extended application of 99mTc-mebrofenin cholescintigraphy with cholecystokinin in the evaluation of abdominal pain of hepatobiliary and gastrointestinal origin.
    Krishnamurthy GT; Krishnamurthy S
    Nucl Med Commun; 2010 May; 31(5):346-54. PubMed ID: 20147863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Precision of the gallbladder ejection fraction obtained with Tc-99m-pyridoxyl-5-methyl-tryptophan (99mTc-PMT) hepatobiliary scintigraphy as compared with the contraction ratio in three-dimensional computed tomography.
    Uchiyama K; Kuniyasu Y; Higashi ST; Shen Y; Niio Y; Hasebe S; Matsuoka S; Shima H; Shinohara H; Takizawa K; Obuchi M; Honda M; Hirata N
    Ann Nucl Med; 1997 May; 11(2):123-8. PubMed ID: 9212892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gallbladder ejection fraction. Nondiagnostic for sphincter of Oddi dysfunction in patients with intact gallbladders.
    Kalloo AN; Sostre S; Meyerrose GE; Pasricha PJ; Szabo Z
    Clin Nucl Med; 1994 Aug; 19(8):713-9. PubMed ID: 7955753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sincalide cholescintigraphy--32 years later: evidence-based data on its clinical utility and infusion methodology.
    Ziessman HA
    Semin Nucl Med; 2012 Mar; 42(2):79-83. PubMed ID: 22293163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.